HORIZON-HLTH-2021-DISEASE-04-03
HORIZON-HLTH-2021-DISEASE-04-03
Programme: Horizon Europe
6 projects · €44,536,973 total EU contribution (project-level) · 67 participating organizations · 31 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€44,536,973
Countries active
Participant organizations by country (headquarters in CORDIS).
- UK (7)
- France (6)
- Germany (5)
- Spain (5)
- Italy (4)
- UG (4)
- KE (3)
- Netherlands (3)
- SE (3)
- ZA (3)
- DK (2)
- MZ (2)
- NO (2)
- AU (1)
- BF (1)
- BJ (1)
- CA (1)
- CH (1)
- EL (1)
- ET (1)
- FI (1)
- GA (1)
- GH (1)
- IE (1)
- MG (1)
- MW (1)
- PL (1)
- PT (1)
- SN (1)
- SZ (1)
- TZ (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- ARMAUER HANSEN RESEARCH INSTITUTE2 projects · ET
- IP2 projects · FR
- INSTITUT PASTEUR DE DAKAR2 projects · SN
- UCPH2 projects · DK
- LSHTM2 projects · UK
- Mologic2 projects · UK
- AdaptVac1 projects · DK
- APHRC1 projects · KE
- ALU-FR1 projects · DE
- ASPHALION1 projects · ES
- BIOECLOSION SL1 projects · ES
- BLUMORPHO1 projects · FR
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Development and validation of a quantitative point-of-care test for the measurement of severity biomarkers to improve risk stratification of fever syndromes and enhance child survival EChiLiBRiST · 101057114 | HORIZON | €6,935,381 | €0 | Details |
A holistic approach in patient management and epidemic surveillance through convergence of diagnostic technologies, capacity building and stakeholder engagement HoliCare · 101057596 | HORIZON | €5,857,774 | €554,004 | Details |
Digital Innovations and Diagnostics for Infectious Diseases in Africa DI-DIDA · 101057251 | HORIZON | €6,468,604 | €498,447 | Details |
SEROLOGICAL TESTING AND TREATMENT FOR P. VIVAX: FROM A CLUSTER-RANDOMISED TRIAL IN ETHIOPIA AND MADAGASCAR TO A MOBILE-TECHNOLOGY SUPPORTED INTERVENTION PvSTATEM · 101057665 | HORIZON | €7,290,778 | €0 | Details |
Dual screening by Spectral Artificial Visual Examination (SAVE) for Female Genital Schistosomiasis (FGS) and cervical cancer. Digital, new, low-cost, and simple screening and training. DUALSAVE-FGS · 101057853 | HORIZON | €7,984,441 | €556,839 | Details |
Advancing The Clinical Development Of Placental Malaria Vaccines In The Context Of Capacity Building and Use Of Digital Health Technologies ADVANCE-VAC4PM · 101057882 | HORIZON | €9,999,995 | €291,780 | Details |